Back to search

National and Kapodistrian University of Athens

Έκφραση παραγόντων νεοαγγειογένεσης σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονος

Abstract

dc:description

Background: Angiogenesis has been proven to be a process related to the migration, proliferation and metastasis of cancer cells. Its predominant moderator is the VEGF which imposes its angiogenetic action through the transmembran receptors VEGFR1 and VEGFR2. The prognostic value of the measurement of these factors in the blood serum of patients is still controversial while their evaluation in the washing has not been studied sufficiently. Aim: The aim of this study is to define the VEGF, VEGFR1 and VEGFR2 and the ratios of VEGF/VEGFR1 and VEGF/VEGFR2 in the blood serum and the washing of patients with newly diagnosed non-small cell lung cancer (NSCLC) and their correlation with the basic clinical characteristics of the patients and the tumors, the treatment response of those who had chemotherapy, the progression free survival (PFS) and the overall survival (OS) of the patients. We will also investigate the correlation of positive VEGF immunohistochemistry with concentration of angiogenic markers in serum and washing. Patients and methods: Forty patients with newly diagnosed NSCLC participated in the current study. The measurement of the circulating and washing levels of VEGF, VEGFR1 and VEGFR2 was carried out with the sandwich enzyme-linked immunosorbent assay (ELISA). For immunohistochemistry we have used specific anti- VEGF (Biogenex, San Ramon, CA). Results: Circulating VEGF levels is correlated with T descriptors in TNM staging system (Ρ=0.021), as well as the ratio VEGF/VEGFR2 in serum and washing (Ρ= 0.03. and Ρ=0.040 relatively). From those who were treated with chemotherapy, best responses were observed in lower concentrations of VEGF in serum and washing (Ρ<0.001). Higher concentrations of VEGF in washing are correlated with worse overall survival (HR 2.208, 95%CI 1.132-4.308, P=0.020) and PFS (HR 2.265, 95%CI 1.145-4.483, P=0.019). Similar results for OS and PFS were observed with high values of the VEGF/VEGFR2 ratio in washing (HR 3.056, 95%CI 1.483-6.297, P=0.002 for survival and HR 3.067, 95%CI 1.508-6.236, P=0.002 for PFS). Multivariate Cox analysis revealed as independent markers for overall survival VEGFR2 levels in serum and washing (Ρ=0.017 και Ρ=0.004 relatively), while for PFS independent markers were VEGFR1 (Ρ= 0.004), VEGF/VEGFR1 (Ρ=0.033) and VEGF/VEGFR2 (Ρ=0.007) in washing. No correlation was noted between IHC-VEGF and circulating or washing angiogenic markers. Conclusions: The circulating VEGF levels are controversial. Nevertheless, the definition of angiogenic markers in washing could recognize a high risk group of patients who could benefit from an aggressive initial therapeutic approach.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Charpidou, Andriani
  • Χαρπίδου, Ανδριανή

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24323

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Charpidou, Andriani; Χαρπίδου, Ανδριανή. Έκφραση παραγόντων νεοαγγειογένεσης σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονος. National and Kapodistrian University of Athens, 2010. http://hdl.handle.net/10442/hedi/24323